As of 2026-06-26, Emerson Electric Co. (EMR) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Technology, ranked 1 of 11. Average daily range 2.8%, relative volume 2.10×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ADR% (20d)avg daily range
2.8%
ATR(14)14-day EMA
$4.46
ATR%ATR as % of close
3.11%
Beta vs SPY90d rolling
1.69
1-ADR stoprisk from close $143.49
$139.51−2.8%
COMPUTED · AS OF 2026-06-26
Pattern read
EMR is in a stage 2 uptrend, week 3. Currently in a 94-day base; basing ADR 2.9% (broad 2.3%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 1.8% / 3.7%.
Pure factual computation. Not a recommendation. See stage analysis.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
EMR ranks at the 58th percentile over 1 month, 63th percentile over 3 months, 56th percentile over 6 months, 52th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
EMR is classified under the Technology sector within the Electrical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Technology is currently ranked 1 of 11 sectors by relative strength.
Yes — Technology ranks at the 100th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). EMR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
EMR currently shows a 20-day average daily range (ADR%) of 2.8%, a 90-day beta versus the S&P 500 of 1.69. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes EMR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what EMR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
EMR most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-05-05. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
10y · since 2022
Best monthJulon averageavg +7.44% · 100% win · n 4
Worst monthAugon averageavg -5.25% · 25% win · n 4